Evidence of Herd Immunity and Sustained Impact of Rotavirus Vaccination on the Reduction of Rotavirus-Related Medical Encounters among Infants from 2006 through 2011 in the United States

Pediatric Infectious Disease Journal

Volumn 34, Issue 6, 2015, Pages 615-620

  Christopher Mast, T ^a   Wang, Florence T ^b   Su, Sue ^b   Seeger, John D ^b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b OPTUM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

acute gastroenteritis; herd immunity; rotavirus; rotavirus gastroenteritis; rotavirus vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; DATA BASE; FEMALE; FOLLOW UP; GASTROENTERITIS; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HERD IMMUNITY; HUMAN; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS GASTROENTERITIS; ROTAVIRUS INFECTION; SEASONAL VARIATION; VACCINATION; COHORT ANALYSIS; IMMUNOLOGY; LONGITUDINAL STUDY; NEWBORN; PROCEDURES; ROTAVIRUS INFECTIONS; UNITED STATES; UTILIZATION;

COHORT STUDIES; FEMALE; GASTROENTERITIS; HUMANS; IMMUNITY, HERD; INCIDENCE; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES; VACCINATION;

EID: 84937700624     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000702     Document Type: Article

References (34)

1. Tate JE, Burton AH, Boschi-Pinto C, WHO-coordinated Global Rotavirus Surveillance Network 2008 Estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012 12 136 141
2. Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC) Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006 55 1 13
3. Mast TC, Walter EB, Bulotsky M, Burden of childhood rotavirus disease on health systems in the United States: results from active surveillance before rotavirus vaccine introduction. Pediatr Infect Dis J 2010 29 e19 e25
4. Tucker AW, Haddix AC, Bresee JS, Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998 279 1371 1376
5. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Human Rotavirus Vaccine Study Group Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006 354 11 22
6. Vesikari T, Matson DO, Dennehy P, Rotavirus Efficacy and Safety Trial (REST) Study Team Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006 354 23 33
7. Vesikari T, Karvonen A, Prymula R, Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007 370 1757 1763
8. Wang FT, Mast TC, Glass RJ, Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010 125 e208 e213
9. Boom JA, Tate JE, Sahni LC, Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010 125 e199 e207
10. Cortes JE, Curns AT, Tate JE, Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011 365 1108 1117
11. Cortese MM, Immergluck LC, Held M, Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013 132 e25 e33
12. Wang FT, Mast TC, Glass RJ, Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States. Pediatr Infect Dis J 2013 32 278 283
13. Loughlin J, Mast TC, Doherty MC, Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2012 31 292 296
14. Shui IM, Baggs J, Patel M, Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012 307 598 604
15. Haber P, Patel M, Pan Y, Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics 2013 131 1042 1049
16. Black CL, Wooten KG, Yankey D, Kolasa M., MMWR National and state vaccination coverage among children aged 19-35 months-United States, 2010. MMWR Morb Mortal Wkly Rep 2011 60 1157 1163
17. Centers for Disease Control and Prevention National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2012. MMWR Morb Mortal Wkly Rep 2013 62 733 756
18. Tate JE, Panozzo CA, Payne DC, Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009 124 465 471
19. Cortese MM, Tate JE, Simonsen L, Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010 29 489 494
20. Curns AT, Steiner CA, Barrett M, Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010 201 1617 1624
21. Payne DC, Staat MA, Edwards KM, New Vaccine Surveillance Network (NVSN) Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011 53 245 253
22. Staat MA, Payne DC, Donauer S, New Vaccine Surveillance Network (NVSN) Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011 128 e267 e275
23. Centers for Disease Control and Prevention Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008 57 697 700
24. Buttery JP, Lambert SB, Grimwood K, Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011 30 1 Suppl S25 S29
25. Anderson EJ, Shippee DB, Weinrobe MH, Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis 2013 56 755 760
26. Gastañaduy PA, Curns AT, Parashar UD, Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013 310 851 853
27. Tate JE, Mutuc JD, Panozzo CA, Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011 30 1 Suppl S30 S34
28. Tate JE, Haynes A, Payne DC, Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr Infect Dis J 2013 32 741 744
29. Kilgore A, Donauer S, Edwards KM, Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact. Vaccine 2013 31 4164 4171
30. Lopman BA, Curns AT, Yen C, Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011 204 980 986
31. Hsu VP, Staat MA, Roberts N, Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics 2005 115 78 82
32. Patel MM, Tate JE, Selvarangan R, Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J 2007 26 914 919
33. Matson DO, Staat MA, Azimi P, Burden of rotavirus hospitalisations in young children in three paediatric hospitals in the United States determined by active surveillance compared to standard indirect methods. J Paediatr Child Health 2012 48 698 704
34. Cortese MM, Dahl RM, Curns AT, Protection against gastroenteritis in US households with children who received rotavirus vaccine. J Infect Dis 2015 211 558 562